SI-BONE, INC. Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price
SI-BONE, INC. (SIBN) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price of $4.42 per share for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice · last filed 2026-08-04
- SI-BONE, INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for the quarter ending 2026-03-31 was $4.58, a 10.37% decline year-over-year.
- SI-BONE, INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for the quarter ending 2025-03-31 was $5.11, a 46.42% increase year-over-year.
- SI-BONE, INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for the quarter ending 2024-03-31 was $3.49, a 19.40% decline year-over-year.
- SI-BONE, INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for the quarter ending 2023-03-31 was $4.33, a 10.72% decline year-over-year.
- SI-BONE, INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2025 was $5.68, a 43.43% increase from fiscal 2024.
- SI-BONE, INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2024 was $3.96, a 36.94% decline from fiscal 2023.
- SI-BONE, INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2023 was $6.28, a 33.62% increase from fiscal 2022.
- SI-BONE, INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2022 was $4.70, a 32.28% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 3 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 9 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 12 month |
|---|---|---|---|---|
| 2026-06-30 | $4.42 10-Q · filed 2026-08-04 | |||
| 2026-03-31 | $4.58 10-Q · filed 2026-05-11 | |||
| 2025-12-31 | $5.68 10-K · filed 2026-02-24 | |||
| 2025-09-30 | $6.72 10-Q · filed 2025-11-10 | |||
| 2025-06-30 | $6.78 10-Q · filed 2025-08-05 | |||
| 2025-03-31 | $5.11 10-Q · filed 2025-05-06 | |||
| 2024-12-31 | $3.96 10-K · filed 2025-02-25 | |||
| 2024-09-30 | $3.97 10-Q · filed 2024-11-12 | |||
| 2024-06-30 | $4.11 10-Q · filed 2024-08-06 | |||
| 2024-03-31 | $3.49 10-Q · filed 2024-05-07 | |||
| 2023-12-31 | $6.28 10-K · filed 2024-02-27 | |||
| 2023-09-30 | $6.36 10-Q · filed 2023-11-07 | |||
| 2023-06-30 | $6.53 10-Q · filed 2023-08-08 | |||
| 2023-03-31 | $4.33 10-Q · filed 2023-05-02 | |||
| 2022-12-31 | $4.70 10-K · filed 2024-02-27 | |||
| 2022-09-30 | $4.75 10-Q · filed 2022-11-08 | |||
| 2022-06-30 | $5.09 10-Q · filed 2022-08-09 | |||
| 2022-03-31 | $4.85 10-Q · filed 2022-05-10 | |||
| 2021-12-31 | $6.94 10-K · filed 2023-03-02 | |||
| 2021-09-30 | $7.34 10-Q · filed 2021-11-09 | |||
| 2021-06-30 | $5.33 10-Q · filed 2021-08-04 | |||
| 2021-03-31 | $6.39 10-Q · filed 2021-05-04 | |||
| 2020-12-31 | $4.52 10-K · filed 2022-03-01 | |||
| 2020-09-30 | $4.34 10-Q · filed 2020-11-03 | |||
| 2020-06-30 | $4.00 10-Q · filed 2020-08-04 | |||
| 2020-03-31 | $4.03 10-Q · filed 2020-05-05 | |||
| 2019-12-31 | $3.36 10-K · filed 2021-03-10 | |||
| 2019-09-30 | $3.29 10-Q · filed 2019-11-12 | |||
| 2019-06-30 | $3.10 10-Q · filed 2019-08-07 | |||
| 2019-03-31 | $2.73 10-Q · filed 2019-05-09 | |||
| 2018-12-31 | $4.08 10-K · filed 2020-03-11 | |||
| 2018-09-30 | $4.11 10-Q · filed 2018-11-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |